Skip to main content

Table 1 Correlation between the clinicopathologic features and expression of NKILA

From: Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway

Characteristics NKILA relative expression N (%) p
Low expression (53) High expression (53)
Age (y)    
  < 60 27 (48.2) 29 (51.8) 0.697
  ≥ 60 26 (52.0) 24 (48.0)
Gender    
 Male 36 (49.3) 37 (50.7) 0.834
 Female 17 (51.5) 16 (48.5)
Differentiated degree    
 Well 1 (1.9) 5 (9.4) 0.212
 Media 33 (62.3) 28 (52.8)
 Poor 19 (35.8) 20 (37.7)
Pathological type    
 Squamous carcinoma 26 (49.1) 27 (50.9) 0.846
 Adenocarcinoma 27 (50.9) 26 (49.1)
Clinical stage    
 I-II 25 (44.1) 34 (55.9) 0.048 *
 III-IV 29 (57.4) 18 (42.6)
T stage    
 I-II 36 (43.4) 47 (56.6) 0.010 *
 III-IV 17 (73.9) 6 (16.1)
Tumor size    
  < 3 cm 10 (32.3) 21 (67.7) 0.019 *
  ≥ 3 cm 43 (57.3) 32 (42.7)
Lymph node metastasis    
 Negative 18 (34.6) 34 (63.4) 0.002 *
 Positive 35 (64.8) 19 (35.2)
  1. *Bolded data indicates statistically significant differences